rel-(αR, βR)-β-(2, 4-Difluorophenyl)-β-hydroxy-α-methyl-1H-1, 2, 4-triazole-1-butanoic acid-d3 Catalog No.:M26409-C RKI-1447 inhibits mammary tumor growth

RKI-1447 inhibits mammary tumor growth by 87% and on average the mammary tumors from RKI-1447 treated mice are 7

LT175 is a dual PPARα/γ ligand

28)29)32-36(17)16-18-8-9-30-23(15-18)35-12-10-34(11-13-35)20-4-5-20/h2-3

AS2521780 is a novel PKCθ selective inhibitor with an IC50 of 0

Formula: C25H23ClN2O3

rel-(αR, βR)-β-(2, 4-Difluorophenyl)-β-hydroxy-α-methyl-1H-1, 2, 4-triazole-1-butanoic acid-d3 Catalog No.:M26409-C RKI-1447 inhibits mammary tumor growthProduct information CAS Number: 1329610 75 4 Molecular Weight: 300. 28 Formula: C13H13F2N3O3 Chemical Name: (2R,3R) 3 (2,4 difluorophenyl) 3 hydroxy 2 (H)methyl 4 (1H 1,2,4 triazol 1 yl)butanoic acid Smiles: [2H]C([2H])([2H])[C@@H](C(O)=O)[C@](O)(CN1C=NC=N1)C1=CC=C(F)C=C1F InChiKey: QUOMTGYGYQRSMC JSFBOPGTSA N InChi: InChI=1S C13H13F2N3O3 c1 8(12(19)20)13(21,5 18 7 16 6 17 18)10 3 2 9(14)4 11(10)15 h2 4,6 8,21H,5H2,1H3,(H,19,20) t8 ,13+ m0 s1 i1D3